Tag

Colinz Laboratories Limited

5 articles
A shift in ownership is underway at Colinz Laboratories, as the Dugar family, led by Padam Dugar, is set to acquire a significant stake and assume co-promoter status. Triggered by an agreement to purchase a 34.56% stake from existing promoter Vijaya Mani, the Dugar family is launching a mandatory open offer to acquire an additional 26% of the company at ₹54 per share. This transaction, coupled with a prior acquisition of 15.01% stake by Padam Dugar and related parties, will result in the acquirers holding a combined 49.56% and exercising joint control, potentially signaling a strategic realignment for the pharmaceutical company and presenting investors with an opportunity to participate in the ownership transition.